Actionable news
All posts from Actionable news
Actionable news in FGEN: FIBROGEN INC,

Fibrogen Appoints Jeffrey Edwards To Board Of Directors

The following excerpt is from the company's SEC filing.

SAN FRANCISCO, October 29, 2015 -- FibroGen, Inc. (FibroGen) (NASDAQ:FGEN), a research-based biopharmaceutical company, today announced that Jeffrey Edwards has been named to the companys board of directors. Mr. Edwards is the former Executive Vice President, Finance and Business Development & Chief Financial Officer of Allergan, Inc.

Jeff has a distinguished record as a pharmaceutical executive with extensive commercial, financial and public company management experience, said Tom Neff, chief executive officer and chairman of the board at FibroGen. His skill set is finely suited to FibroGen as we beg in to plan with our partners for worldwide commercial efforts for roxadustat and the advancement of other core programs. On behalf of FibroGen and the Board of Directors, I welcome Jeff and look forward to drawing on his strategic, operational and financial...